Table 1 summarizes Bmi-1’s recognized roles in head and neck cancers. In this context, tumor-causing cells express Bmi-1 at a higher level than do healthy cells. Moreover, overexpression of Bmi-1 has been linked to drug resistance and tumor growth, making it a promising therapeutic target in recent years [1]. Here, BMI1 is linked to neoplasm.